Key Points
- Several manufacturers are developing femtosecond laser technology as a tool for multiple applications in cataract surgery.
These surgeons summarise its many uses and initial promising results.
In September, the first femtosecond laser (LenSx, LenSx Lasers) designed for cataract surgery received FDA 510(k) clearance
for use in anterior capsulotomy.
This device, however, also has capabilities for enabling and improving additional surgical manoeuvres, and other manufacturers,
including Abbott Medical Optics, LensAR, and OptiMedica, are developing femtosecond lasers for use as multitasking tools in
cataract surgery as well.
"For over 40 years since the advent of small-incision phaco by Dr. Charles Kelman many of the important aspects of cataract
surgery have been performed manually with the possibility of imprecision and even complications," said Dr. William W. Culbertson,
at this year's ESCRS Congress. "In recent years, engineers, scientists, physicists, and ophthalmologists have been collaborating
to develop the femtosecond laser to improve these steps.
"Just as the femtosecond laser has improved the safety and predictability of LASIK flap creation, so, too, will it improve
the safety, predictability, and surgeon control in cataract procedures," said Dr. Culbertson, holder of the Lou Higgins Distinguished
Chair in Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. He presented experience performing capsulorhexis, nuclear segmentation, and nuclear softening using a femtosecond laser that
is being developed by OptiMedica. The information was from a feasibility study performed in collaboration with Juan Batlle,
MD, Santo Domingo, Dominican Republic, and done using a prototype device.
 Figure 1
|
In the same ESCRS session, Dr. Zoltan Nagy, professor of ophthalmology, Semmelweis University, Budapest, Hungary, described
the use of the femtosecond laser from LenSx Lasers for performing capsulorhexis and to create corneal incisions and soften
the nucleus to enable aspiration.
For the study with the femtosecond laser in development by OptiMedica, proprietary treatment-planning software allowed the
surgeon to design the capsulotomy diameter and the depth and pattern of nuclear segmentation. Then, real-time optical coherence
tomography (OCT) was used for guidance at the time of the procedure. The study population comprised 20 sighted human eyes
with grade 2 to 4 nuclear cataracts and no anterior segment pathology.
The laser was used to create 5 mm, 5.5 mm and 6 mm capsulotomies and to perform four-quadrant nuclear segmentation and four-quadrant
nuclear softening on harder lenses. In all eyes, the capsulorhexis was within 0.1 mm of the intended size, Dr. Culbertson
said.
"The capsulotomy edge was without defects and smooth, very similar to what we would see in a manually created capsulorhexis,"
he said. The four-quadrant nuclear segmentations were performed with predetermined diameters ranging from 4.5mm to 6 mm and
by cutting from the bottom up. Initially they were started at 80% nuclear depth, but as confidence increased, the depth was
increased to 90%, leaving a 500-μm lens cushion.
 Figure 2
|
Dr. Culbertson reported the presegmentation facilitated quadrant separation, and nuclear softening facilitated rapid phaco-assisted
nucleus aspiration. "Use of the femtosecond laser essentially converted a grade 4 nuclear cataract into a grade 2 nuclear
cataract so that we were often able to turn off the longitudinal phaco and just use the torsional mode," he said.